SAN RAMON, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO), will participate in the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:20 PM ET.
A live webcast of the Company’s session can be accessed from Cooper’s investor relations website at http://investor.coopercos.com. A replay will be available on the same web page following the event.
About CooperCompanies
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
SINGAPORE, June 7, 2024 /PRNewswire/ -- Zeta Surgical, a surgical robotics and mixed reality company, announced…
TRIOS Core - New TRIOS intraoral scanner system for just $12,400Remodeled TRIOS 3 intraoral scanner…
MUNICH, June 6, 2024 /PRNewswire/ -- According to the World Health Organization (WHO), at least…
KANAZAWA, Japan, June 7, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report…
UPPSALA, SWEDEN / ACCESSWIRE / June 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Uppsala, Sweden - Senzime…
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 7, 2024 / Biophytis SA (Euronext…